COVID-19 Impact on Global Non Narcotic Analgesics, Market Insights and Forecast to 2026

Publisher Name :
Date: 23-Jun-2020
No. of pages: 116
Inquire Before Buying

Non Narcotic Analgesics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non Narcotic Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non Narcotic Analgesics market is segmented into

- Non Steroid Antiinflammatory Drug

- Steroid Antiinflammatory Drug

Segment by Application, the Non Narcotic Analgesics market is segmented into

- Hospital

- Medical Center

- Others

Regional and Country-level Analysis

The Non Narcotic Analgesics market is analysed and market size information is provided by regions (countries).

The key regions covered in the Non Narcotic Analgesics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Non Narcotic Analgesics Market Share Analysis

Non Narcotic Analgesics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non Narcotic Analgesics business, the date to enter into the Non Narcotic Analgesics market, Non Narcotic Analgesics product introduction, recent developments, etc.

The major vendors covered:

- Sanofi S.A.

- Novartis AG

- GlaxoSmithKline PLC

- Pfizer

- Reckitt Benckiser

- Endo Pharmaceuticals

- ...

COVID-19 Impact on Global Non Narcotic Analgesics, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Non Narcotic Analgesics Product Introduction
1.2 Market Segments
1.3 Key Non Narcotic Analgesics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Non Narcotic Analgesics Market Size Growth Rate by Type
1.4.2 Non Steroid Antiinflammatory Drug
1.4.3 Steroid Antiinflammatory Drug
1.5 Market by Application
1.5.1 Global Non Narcotic Analgesics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Center
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Non Narcotic Analgesics Industry Impact
1.6.1 How the Covid-19 is Affecting the Non Narcotic Analgesics Industry
1.6.1.1 Non Narcotic Analgesics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Non Narcotic Analgesics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Non Narcotic Analgesics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Non Narcotic Analgesics Market Size Estimates and Forecasts
2.1.1 Global Non Narcotic Analgesics Revenue 2015-2026
2.1.2 Global Non Narcotic Analgesics Sales 2015-2026
2.2 Non Narcotic Analgesics Market Size by Region: 2020 Versus 2026
2.2.1 Global Non Narcotic Analgesics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Non Narcotic Analgesics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Non Narcotic Analgesics Competitor Landscape by Players
3.1 Non Narcotic Analgesics Sales by Manufacturers
3.1.1 Non Narcotic Analgesics Sales by Manufacturers (2015-2020)
3.1.2 Non Narcotic Analgesics Sales Market Share by Manufacturers (2015-2020)
3.2 Non Narcotic Analgesics Revenue by Manufacturers
3.2.1 Non Narcotic Analgesics Revenue by Manufacturers (2015-2020)
3.2.2 Non Narcotic Analgesics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Non Narcotic Analgesics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Non Narcotic Analgesics Revenue in 2019
3.2.5 Global Non Narcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Non Narcotic Analgesics Price by Manufacturers
3.4 Non Narcotic Analgesics Manufacturing Base Distribution, Product Types
3.4.1 Non Narcotic Analgesics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non Narcotic Analgesics Product Type
3.4.3 Date of International Manufacturers Enter into Non Narcotic Analgesics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Non Narcotic Analgesics Market Size by Type (2015-2020)
4.1.1 Global Non Narcotic Analgesics Sales by Type (2015-2020)
4.1.2 Global Non Narcotic Analgesics Revenue by Type (2015-2020)
4.1.3 Non Narcotic Analgesics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Non Narcotic Analgesics Market Size Forecast by Type (2021-2026)
4.2.1 Global Non Narcotic Analgesics Sales Forecast by Type (2021-2026)
4.2.2 Global Non Narcotic Analgesics Revenue Forecast by Type (2021-2026)
4.2.3 Non Narcotic Analgesics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Non Narcotic Analgesics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Non Narcotic Analgesics Market Size by Application (2015-2020)
5.1.1 Global Non Narcotic Analgesics Sales by Application (2015-2020)
5.1.2 Global Non Narcotic Analgesics Revenue by Application (2015-2020)
5.1.3 Non Narcotic Analgesics Price by Application (2015-2020)
5.2 Non Narcotic Analgesics Market Size Forecast by Application (2021-2026)
5.2.1 Global Non Narcotic Analgesics Sales Forecast by Application (2021-2026)
5.2.2 Global Non Narcotic Analgesics Revenue Forecast by Application (2021-2026)
5.2.3 Global Non Narcotic Analgesics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Non Narcotic Analgesics by Country
6.1.1 North America Non Narcotic Analgesics Sales by Country
6.1.2 North America Non Narcotic Analgesics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Non Narcotic Analgesics Market Facts & Figures by Type
6.3 North America Non Narcotic Analgesics Market Facts & Figures by Application
7 Europe
7.1 Europe Non Narcotic Analgesics by Country
7.1.1 Europe Non Narcotic Analgesics Sales by Country
7.1.2 Europe Non Narcotic Analgesics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non Narcotic Analgesics Market Facts & Figures by Type
7.3 Europe Non Narcotic Analgesics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Non Narcotic Analgesics by Region
8.1.1 Asia Pacific Non Narcotic Analgesics Sales by Region
8.1.2 Asia Pacific Non Narcotic Analgesics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Non Narcotic Analgesics Market Facts & Figures by Type
8.3 Asia Pacific Non Narcotic Analgesics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Non Narcotic Analgesics by Country
9.1.1 Latin America Non Narcotic Analgesics Sales by Country
9.1.2 Latin America Non Narcotic Analgesics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Non Narcotic Analgesics Market Facts & Figures by Type
9.3 Central & South America Non Narcotic Analgesics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Non Narcotic Analgesics by Country
10.1.1 Middle East and Africa Non Narcotic Analgesics Sales by Country
10.1.2 Middle East and Africa Non Narcotic Analgesics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Non Narcotic Analgesics Market Facts & Figures by Type
10.3 Middle East and Africa Non Narcotic Analgesics Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Non Narcotic Analgesics Products Offered
11.1.5 Sanofi S.A. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description, Business Overview and Total Revenue
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Non Narcotic Analgesics Products Offered
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Corporation Information
11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Non Narcotic Analgesics Products Offered
11.4.5 Pfizer Recent Development
11.5 Reckitt Benckiser
11.5.1 Reckitt Benckiser Corporation Information
11.5.2 Reckitt Benckiser Description, Business Overview and Total Revenue
11.5.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Reckitt Benckiser Non Narcotic Analgesics Products Offered
11.5.5 Reckitt Benckiser Recent Development
11.6 Endo Pharmaceuticals
11.6.1 Endo Pharmaceuticals Corporation Information
11.6.2 Endo Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Endo Pharmaceuticals Non Narcotic Analgesics Products Offered
11.6.5 Endo Pharmaceuticals Recent Development
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Non Narcotic Analgesics Products Offered
11.1.5 Sanofi S.A. Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Non Narcotic Analgesics Market Estimates and Projections by Region
12.1.1 Global Non Narcotic Analgesics Sales Forecast by Regions 2021-2026
12.1.2 Global Non Narcotic Analgesics Revenue Forecast by Regions 2021-2026
12.2 North America Non Narcotic Analgesics Market Size Forecast (2021-2026)
12.2.1 North America: Non Narcotic Analgesics Sales Forecast (2021-2026)
12.2.2 North America: Non Narcotic Analgesics Revenue Forecast (2021-2026)
12.2.3 North America: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
12.3 Europe Non Narcotic Analgesics Market Size Forecast (2021-2026)
12.3.1 Europe: Non Narcotic Analgesics Sales Forecast (2021-2026)
12.3.2 Europe: Non Narcotic Analgesics Revenue Forecast (2021-2026)
12.3.3 Europe: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Non Narcotic Analgesics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Non Narcotic Analgesics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Non Narcotic Analgesics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Non Narcotic Analgesics Market Size Forecast by Region (2021-2026)
12.5 Latin America Non Narcotic Analgesics Market Size Forecast (2021-2026)
12.5.1 Latin America: Non Narcotic Analgesics Sales Forecast (2021-2026)
12.5.2 Latin America: Non Narcotic Analgesics Revenue Forecast (2021-2026)
12.5.3 Latin America: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Non Narcotic Analgesics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Non Narcotic Analgesics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Non Narcotic Analgesics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Non Narcotic Analgesics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non Narcotic Analgesics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Non Narcotic Analgesics Market Segments
Table 2. Ranking of Global Top Non Narcotic Analgesics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Non Narcotic Analgesics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Non Steroid Antiinflammatory Drug
Table 5. Major Manufacturers of Steroid Antiinflammatory Drug
Table 6. COVID-19 Impact Global Market: (Four Non Narcotic Analgesics Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Non Narcotic Analgesics Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Non Narcotic Analgesics Players to Combat Covid-19 Impact
Table 11. Global Non Narcotic Analgesics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Non Narcotic Analgesics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Non Narcotic Analgesics Sales by Regions 2015-2020 (K MT)
Table 14. Global Non Narcotic Analgesics Sales Market Share by Regions (2015-2020)
Table 15. Global Non Narcotic Analgesics Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Non Narcotic Analgesics Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Non Narcotic Analgesics Sales Share by Manufacturers (2015-2020)
Table 18. Global Non Narcotic Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Non Narcotic Analgesics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Narcotic Analgesics as of 2019)
Table 20. Non Narcotic Analgesics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Non Narcotic Analgesics Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Non Narcotic Analgesics Price (2015-2020) (USD/MT)
Table 23. Non Narcotic Analgesics Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Non Narcotic Analgesics Product Type
Table 25. Date of International Manufacturers Enter into Non Narcotic Analgesics Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 28. Global Non Narcotic Analgesics Sales Share by Type (2015-2020)
Table 29. Global Non Narcotic Analgesics Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Non Narcotic Analgesics Revenue Share by Type (2015-2020)
Table 31. Non Narcotic Analgesics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 33. Global Non Narcotic Analgesics Sales Share by Application (2015-2020)
Table 34. North America Non Narcotic Analgesics Sales by Country (2015-2020) (K MT)
Table 35. North America Non Narcotic Analgesics Sales Market Share by Country (2015-2020)
Table 36. North America Non Narcotic Analgesics Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Non Narcotic Analgesics Revenue Market Share by Country (2015-2020)
Table 38. North America Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 39. North America Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Table 40. North America Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 41. North America Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Table 42. Europe Non Narcotic Analgesics Sales by Country (2015-2020) (K MT)
Table 43. Europe Non Narcotic Analgesics Sales Market Share by Country (2015-2020)
Table 44. Europe Non Narcotic Analgesics Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Non Narcotic Analgesics Revenue Market Share by Country (2015-2020)
Table 46. Europe Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 47. Europe Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Table 48. Europe Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 49. Europe Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Non Narcotic Analgesics Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Non Narcotic Analgesics Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Non Narcotic Analgesics Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Non Narcotic Analgesics Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Table 58. Latin America Non Narcotic Analgesics Sales by Country (2015-2020) (K MT)
Table 59. Latin America Non Narcotic Analgesics Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Non Narcotic Analgesics Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Non Narcotic Analgesics Revenue Market Share by Country (2015-2020)
Table 62. Latin America Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 63. Latin America Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Table 64. Latin America Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 65. Latin America Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Non Narcotic Analgesics Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Non Narcotic Analgesics Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Non Narcotic Analgesics Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Non Narcotic Analgesics Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Non Narcotic Analgesics Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Non Narcotic Analgesics Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Table 74. Sanofi S.A. Corporation Information
Table 75. Sanofi S.A. Description and Major Businesses
Table 76. Sanofi S.A. Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi S.A. Product
Table 78. Sanofi S.A. Recent Development
Table 79. Novartis AG Corporation Information
Table 80. Novartis AG Description and Major Businesses
Table 81. Novartis AG Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis AG Product
Table 83. Novartis AG Recent Development
Table 84. GlaxoSmithKline PLC Corporation Information
Table 85. GlaxoSmithKline PLC Description and Major Businesses
Table 86. GlaxoSmithKline PLC Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline PLC Product
Table 88. GlaxoSmithKline PLC Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Reckitt Benckiser Corporation Information
Table 95. Reckitt Benckiser Description and Major Businesses
Table 96. Reckitt Benckiser Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Reckitt Benckiser Product
Table 98. Reckitt Benckiser Recent Development
Table 99. Endo Pharmaceuticals Corporation Information
Table 100. Endo Pharmaceuticals Description and Major Businesses
Table 101. Endo Pharmaceuticals Non Narcotic Analgesics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Endo Pharmaceuticals Product
Table 103. Endo Pharmaceuticals Recent Development
Table 104. Global Non Narcotic Analgesics Sales Forecast by Regions (2021-2026) (K MT)
Table 105. Global Non Narcotic Analgesics Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Non Narcotic Analgesics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Non Narcotic Analgesics Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Non Narcotic Analgesics Sales Forecast by Country (2021-2026) (K MT)
Table 109. North America: Non Narcotic Analgesics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Non Narcotic Analgesics Sales Forecast by Country (2021-2026) (K MT)
Table 111. Europe: Non Narcotic Analgesics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Non Narcotic Analgesics Sales Forecast by Region (2021-2026) (K MT)
Table 113. Asia Pacific: Non Narcotic Analgesics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Non Narcotic Analgesics Sales Forecast by Country (2021-2026) (K MT)
Table 115. Latin America: Non Narcotic Analgesics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Non Narcotic Analgesics Sales Forecast by Country (2021-2026) (K MT)
Table 117. Middle East and Africa: Non Narcotic Analgesics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Non Narcotic Analgesics Players
Table 122. Non Narcotic Analgesics Customers List
Table 123. Non Narcotic Analgesics Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Non Narcotic Analgesics Product Picture
Figure 2. Global Non Narcotic Analgesics Sales Market Share by Type in 2020 & 2026
Figure 3. Non Steroid Antiinflammatory Drug Product Picture
Figure 4. Steroid Antiinflammatory Drug Product Picture
Figure 5. Global Non Narcotic Analgesics Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Medical Center
Figure 8. Others
Figure 9. Non Narcotic Analgesics Report Years Considered
Figure 10. Global Non Narcotic Analgesics Market Size 2015-2026 (US$ Million)
Figure 11. Global Non Narcotic Analgesics Sales 2015-2026 (K MT)
Figure 12. Global Non Narcotic Analgesics Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Non Narcotic Analgesics Sales Market Share by Region (2015-2020)
Figure 14. Global Non Narcotic Analgesics Sales Market Share by Region in 2019
Figure 15. Global Non Narcotic Analgesics Revenue Market Share by Region (2015-2020)
Figure 16. Global Non Narcotic Analgesics Revenue Market Share by Region in 2019
Figure 17. Global Non Narcotic Analgesics Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Non Narcotic Analgesics Revenue in 2019
Figure 19. Non Narcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Non Narcotic Analgesics Sales Market Share by Type (2015-2020)
Figure 21. Global Non Narcotic Analgesics Sales Market Share by Type in 2019
Figure 22. Global Non Narcotic Analgesics Revenue Market Share by Type (2015-2020)
Figure 23. Global Non Narcotic Analgesics Revenue Market Share by Type in 2019
Figure 24. Global Non Narcotic Analgesics Market Share by Price Range (2015-2020)
Figure 25. Global Non Narcotic Analgesics Sales Market Share by Application (2015-2020)
Figure 26. Global Non Narcotic Analgesics Sales Market Share by Application in 2019
Figure 27. Global Non Narcotic Analgesics Revenue Market Share by Application (2015-2020)
Figure 28. Global Non Narcotic Analgesics Revenue Market Share by Application in 2019
Figure 29. North America Non Narcotic Analgesics Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Non Narcotic Analgesics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Non Narcotic Analgesics Sales Market Share by Country in 2019
Figure 32. North America Non Narcotic Analgesics Revenue Market Share by Country in 2019
Figure 33. U.S. Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Non Narcotic Analgesics Market Share by Type in 2019
Figure 38. North America Non Narcotic Analgesics Market Share by Application in 2019
Figure 39. Europe Non Narcotic Analgesics Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Non Narcotic Analgesics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Non Narcotic Analgesics Sales Market Share by Country in 2019
Figure 42. Europe Non Narcotic Analgesics Revenue Market Share by Country in 2019
Figure 43. Germany Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Non Narcotic Analgesics Market Share by Type in 2019
Figure 54. Europe Non Narcotic Analgesics Market Share by Application in 2019
Figure 55. Asia Pacific Non Narcotic Analgesics Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Non Narcotic Analgesics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Non Narcotic Analgesics Sales Market Share by Region in 2019
Figure 58. Asia Pacific Non Narcotic Analgesics Revenue Market Share by Region in 2019
Figure 59. China Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Non Narcotic Analgesics Market Share by Type in 2019
Figure 82. Asia Pacific Non Narcotic Analgesics Market Share by Application in 2019
Figure 83. Latin America Non Narcotic Analgesics Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Non Narcotic Analgesics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Non Narcotic Analgesics Sales Market Share by Country in 2019
Figure 86. Latin America Non Narcotic Analgesics Revenue Market Share by Country in 2019
Figure 87. Mexico Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Non Narcotic Analgesics Market Share by Type in 2019
Figure 94. Latin America Non Narcotic Analgesics Market Share by Application in 2019
Figure 95. Middle East and Africa Non Narcotic Analgesics Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Non Narcotic Analgesics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Non Narcotic Analgesics Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Non Narcotic Analgesics Revenue Market Share by Country in 2019
Figure 99. Turkey Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Non Narcotic Analgesics Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Non Narcotic Analgesics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Non Narcotic Analgesics Market Share by Type in 2019
Figure 106. Middle East and Africa Non Narcotic Analgesics Market Share by Application in 2019
Figure 107. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Reckitt Benckiser Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Non Narcotic Analgesics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Non Narcotic Analgesics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Non Narcotic Analgesics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Non Narcotic Analgesics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Non Narcotic Analgesics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Non Narcotic Analgesics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Non Narcotic Analgesics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Non Narcotic Analgesics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Non Narcotic Analgesics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Non Narcotic Analgesics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs